Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,427 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    R&D Pharma Acquired By Weekend Unlimited

    On Feb. 20, 2019, Weekend Unlimited Inc. (CSE: POT) (FSE: 0OS1) (OTCMKTS: WKULF) completed its previously announced arms-length acquisition of R&D Pharma Corp.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Santé Canada et la Food and Drug Administration des États-Unis conviennent de mettre en place un programme de partage d'informations pour l'examen des médicaments génériques

    Santé Canada et la Food and Drug Administration des États-Unis (la « FDA ») ont créé un programme visant à soutenir la mise en place d'un programme de Demande de partage d'informations (« DPI »)...
    CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
  • Article

    Santé canada sollicite les commentaires sur le projet de lignes directrices intitulé « Guidance on the Application of Human Factors to Consumer Products »

    The draft guidance document is not a rule and does not establish legally enforceable responsibilities.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Stikeman Elliott LLP
    Stikeman Elliott LLP
  • Article

    The Advancing Oversight And Planning Ontario's Health System Act, 2021; The Proposed Regulation Of Personal Support Workers, Physician Assistants And Behaviour Analysts

    Every day, thousands of Ontarians receive vital care from unregulated health care providers including personal support workers ("PSWs"), physician assistants, and behaviour analysts.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Torkin Manes LLP
    Torkin Manes LLP
  • Video

    The Legal Steps To Startups: Health & Life Science (Video)

    The Health and Life Science industry in Alberta is diverse and growing, and approaching the protection of proprietary information in the health and life science field comes...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Parlee McLaws LLP
    Parlee McLaws LLP
  • Article

    Update On Proposed Ministerial Reliance Order

    As we reported last month, the Minister of Health launched a consultation on a proposed Ministerial Reliance Order that would permit Health Canada to complete the examination of certain parts...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Declines To Overturn Prohibition On Patenting Methods Of Medical Treatment

    The Supreme Court of Canada has issued a landmark ruling on whether methods of medical treatment can be patented in Canada, addressing a long-standing prohibition that has shaped the country's intellectual property landscape. The decision examines the boundaries between patentable medical innovations and unpatentable professional medical judgment, with particular focus on dosing regimens and treatment protocols. This ruling provides critical guidance for pharmaceutical companies, patent practitioners, and h
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Video: What Does A New Ruling On Canada's Equivalent To Patent Term Extension Mean For The Pharmaceutical Industry?

    Last week, we wrote about the Federal Court's latest judicial review which sheds light on how courts may view eligibility of patents for Canada's recently introduced Certificates of Supplementary Protection (CSPs).
    CanadaIntellectual Property
    Torys
    Torys
  • Video

    What Does A New Ruling On Canada's Equivalent To Patent Term Extension Mean For The Pharmaceutical Industry? (Video)

    What does a new ruling on Canada's equivalent to patent term extension mean for the pharmaceutical industry?
    CanadaIntellectual Property
    Torys
    Torys
  • Article

    2020 Awards Of Excellence In Brain Injury Rehabilitation

    Nominations are now open for the 2020 Awards of Excellence in Brain Injury Rehabilitation. Nominate from June 1 to July 3 for any of the five Awards of Excellence
    CanadaLitigation, Mediation & Arbitration
    McLeish Orlando LLP
    McLeish Orlando LLP
  • Article

    B.C. Government Introduces Bill 12 – 2024 Public Health Accountability And Cost Recovery Act

    On March 14, 2024, the B.C. government introduced for first reading Bill 12 – 2024, Public Health Accountability and Cost Recovery Act.
    CanadaLitigation, Mediation & Arbitration
    Lawson Lundell LLP
    Lawson Lundell LLP
  • Video

    Expert Medical Evidence In Support Of Future Care Claims With Dr. Peter Rumney And Richard Halpern (Video)

    Gluckstein Lawyers' 4th Annual Risky Business Conference: Case Updates and Practical Tips took place using a hybrid model, on November 29, 2022, from 9:00 AM to 4:00 PM. Our Risky...
    CanadaLitigation, Mediation & Arbitration
    Gluckstein Lawyers
    Gluckstein Lawyers
  • Article

    In PM(NOC) Litigation, The Pleadings Rule

    Since the amendments to the PM(NOC) Regulations in 2017, both generic and brand side litigants have struggled with the question of whether the second person's Notice of Allegation...
    CanadaLitigation, Mediation & Arbitration
    Lenczner Slaght
    Lenczner Slaght
  • Article

    Medical Malpractice: Effective Advocacy (Video)

    Bethany Nicholson, Associate at Gluckstein Lawyers, shares her expertise on effective advocacy in medical malpractice cases in this session from Risky Business 2025.
    CanadaLitigation, Mediation & Arbitration
    Gluckstein Lawyers
    Gluckstein Lawyers
  • Article

    New Court Proceedings - December 2020

    REVLIMID (lenalidomide): Celgene v Taro.
    CanadaLitigation, Mediation & Arbitration
    Smart & Biggar
    Smart & Biggar
  • Article

    Canadian Privacy Commissioner Finds Privacy Act Violation By Federal Department

    On March 16, the Office of the Privacy Commissioner of Canada ruled that a federal department responsible for helping Canadians maintain and improve their health violated federal privacy law...
    CanadaPrivacy
    Jones Day
    Jones Day
  • Article

    Eli Health Secures C$17M To Bring Hormone Testing To The Home

    Eli Science Inc. ("Eli Health"), a Montreal-based startup, has secured C$17 million in Series A funding to launch its at-home hormone monitoring technology.
    CanadaTechnology
    Goodmans LLP
    Goodmans LLP
  • Article

    February 2025 Rosen Sunshine Newsletter

    Our February 2025 newsletter is now out. In this issue...
    CanadaTechnology
    Rosen Sunshine LLP
    Rosen Sunshine LLP
  • Article

    COVID-19 – What You Need To Know

    As the cases of COVID-19 increase around the world, we continue to implement precautionary measures to ensure the health and safety of our people, their families, our clients and our communities.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Torkin Manes LLP
    Torkin Manes LLP
  • Article

    Keeping You Up-To-Date On Consumer Product Regulation - What’s New With The Canada Consumer Product Safety Act?

    An update on Health Canada’s consumer product safety transparency initiative and a note on the prohibition on toys and children’s products that contain TCEP in polyurethane foam.
    CanadaConsumer Protection
    Cassels
    Cassels
  • Showing 161–180 of 3427 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics